CN Patent

CN106031710B — 一种富马酸氟呐普拉赞的注射剂及其制备方法

Assigned to Nanjing Yoko Biological Pharmaceutical Group Co Ltd · Expires 2019-03-12 · 7y expired

What this patent protects

本发明属于药物制剂技术领域，尤其涉及一种具有治疗胃酸相关性疾病作用的钾离子竞争性酸阻滞剂：富马酸氟呐普拉赞的注射剂及其制备方法。本发明克服了主药富马酸氟呐普拉赞的水溶性差的缺陷，采用磺丁基醚‑β‑环糊精或者羟丙基‑β‑环糊精的包合形式进行増溶，制备所得的注射剂具有稳定性好，安全性高，长期放置不沉淀等优势，能够满足不方便口服给药病人的用药需求。

USPTO Abstract

本发明属于药物制剂技术领域，尤其涉及一种具有治疗胃酸相关性疾病作用的钾离子竞争性酸阻滞剂：富马酸氟呐普拉赞的注射剂及其制备方法。本发明克服了主药富马酸氟呐普拉赞的水溶性差的缺陷，采用磺丁基醚‑β‑环糊精或者羟丙基‑β‑环糊精的包合形式进行増溶，制备所得的注射剂具有稳定性好，安全性高，长期放置不沉淀等优势，能够满足不方便口服给药病人的用药需求。

Drugs covered by this patent

Patent Metadata

Patent number
CN106031710B
Jurisdiction
CN
Classification
—
Expires
2019-03-12
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Yoko Biological Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.